AHA Coding Clinic® for HCPCS - 2005 Quarter 2; FOR your INFORMATION
Billing and payment for Vinorelbine Tartrate
Inadvertently, Vinorelbine Tartrate was misclassified as a sole source product in the 2005 outpatient prospective payment system (OPPS) final rule. The Centers for Medicare & Medicaid Services (CMS) has since reclassified Vinorelbine Tartrate as a multi-source product. The HCPCS codes and payment amount for both the generic and brand name form of the drug are listed below. HCPCS SI APC Short Descriptor Long Descriptor Payment Rate Minimum Unadjusted Copayment Effective Date J9390 K 0855 Vinorelbine tartrate per 10 mg Vinorelbine Tartrate, per 10 mg $52.78 $10.56 01/01/05 C9440 K 9440 Vinorelbine tartrate, brand Vinorelbine Tartrate, brand, per...
Subscribe or sign in to view the full article.
Article Overview
This article explains Medicare outpatient billing and payment information for Vinorelbine Tartrate and is intended for coders, billing staff, and reimbursement professionals reviewing drug payment references. It covers the HCPCS coding associated with the product, APC-related classification, payment rate details, copayment information, and the effective date of the listed guidance.
Why This Topic Matters
It helps readers quickly identify the official outpatient payment reference for this drug and understand which billing identifiers are listed in the source material.
What You Will Learn
- How the article presents outpatient billing and payment reference information for Vinorelbine Tartrate
- Which code sets and payment-related fields are included in the source table
- What effective date accompanies the listed Medicare outpatient information
- How the article distinguishes the generic and brand-name entries at a high level
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Hospital outpatient reimbursement specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com